Profound Medical Celebrates The Hong Center's 200th Independent TULSA Procedure for Prostate Disease Life Science Investing
Arcellx to Host Investor Relations Event During the 67th ASH Annual Meeting and Exposition Life Science Investing
Bristol Myers Squibb Announces Accepted Amounts and Pricing Terms of its Tender Offers Life Science Investing
AbbVie Announces U.S. FDA Approval of EPKINLY® in Combination with Rituximab and Lenalidomide for Relapsed or Refractory Follicular Lymphoma Pharmaceutical Investing
Arrowhead Pharmaceuticals Announces FDA Approval of REDEMPLO® to Reduce Triglycerides in Adults with Familial Chylomicronemia Syndrome Life Science Investing
Rain Enhancement Technologies Secures Second U.S. Installation with Utah Permit Approval, Advances Snow Enhancement Capabilities Life Science Investing
Sonnet BioTherapeutics Holdings, Inc. Announces Adjournment of Special Meeting Life Science Investing
ABVC BioPharma Receives US$240,000 Licensing Payment From OncoX BioPharma; Total Licensing Payments Reach Approximately US$2.53 Million Life Science Investing
